Compare CNTN & CHEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTN | CHEC |
|---|---|---|
| Founded | 2017 | 2024 |
| Country | United States | Singapore |
| Employees | 12 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 175.5M |
| IPO Year | 2022 | N/A |
| Metric | CNTN | CHEC |
|---|---|---|
| Price | $2.84 | $10.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 42.9K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.14 | $9.91 |
| 52 Week High | $5.27 | $10.56 |
| Indicator | CNTN | CHEC |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 66.02 |
| Support Level | $2.14 | $10.02 |
| Resistance Level | $3.80 | $10.47 |
| Average True Range (ATR) | 0.31 | 0.00 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 19.83 | 100.00 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Chenghe Acquisition III Co is blank check company.